For the Inventor, By the Inventor

Enter assignee name

Pamplona, Spain

Proyecto De Biomedicina Cima, S.l.

USPTO Granted Patents = 17

CIPO Patents = 4

EPO Patents = 20

Forward Citations = 55

Loading Chart...

Loading Chart...

58 inventors (with patents filed for the assignee):

Jesús Maria Prieto Valtueña (6 out of 7 patents)

Juan José Lasarte Sagastibelza (4 out of 7 patents)

Josune Orbe Lopategui (3 out of 3 patents)

4. Esther Larrea Leoz (3 out of 3 patents)

5. Inés Noelia Casares Lagar (2 out of 4 patents)

6. José Antonio Páramo Fernández (2 out of 2 patents)

7. Juan Jose Lasarte Sagastibelza (2 out of 2 patents)

8. Jesus Prieto Valtuena (2 out of 3 patents)

9. Rosario Serrano Vargas (2 out of 2 patents)

10. Francisco Borrás Cuesta (2 out of 3 patents)

11. Pablo Sarobe Ugarriza (2 out of 2 patents)

12. Beatriz Moreno Bruna (2 out of 2 patents)

13. Pablo Villoslada Díaz (2 out of 2 patents)

14. Javier Dotor De Las Herrerías (2 out of 2 patents)

15. Francisco Borras Cuesta (2 out of 4 patents)

17 patents: Sort by Forward Citations

1. 10545150 - Lung cancer molecular markers (2020-01-28),

2. 9440989 - Antifibrinolytic compounds (2016-09-13),

3. 9155783 - Agents and methods based on the use of the EDA domain of fibronectin (2015-10-13),

4. 8697665 - Porphobilinogen deaminase gene therapy (2014-04-15),

5. 8541370 - Use of matrix metalloproteinase-10 (MMP-10) for thrombolytic treatments (2013-09-24),

6. 8524860 - Peptides with capacity to bind to scurfin and applications (2013-09-03),

7. 8257701 - Methods for anti-fibrinolytic treatment using MMP-10 neutralizing antibody (2012-09-04),

8. 8236778 - Synergistic 5'-methylthioadenosine combinations (2012-08-07),

9. 8148334 - Peptides with capacity for binding with interleukine 10 (IL-10) (2012-04-03),

10. 8012973 - Compounds for the treatment of auricular fibrillation (2011-09-06),

11. 7829077 - Treatment of hepatitis C with compositions comprising oncostatin M and interferon alpha (2010-11-09),

12. 7820637 - Use of 5'-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection (2010-10-26),

13. 7732397 - Use of cardiotrophin in liver diseases (2010-06-08),

14. 7666841 - Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1) (2010-02-23),

15. 7501392 - Method of treatment of viral hepatitis C with interferon alpha 5 (2009-03-10),

PROYECTO DE BIOMEDICINA CIMA, S.L. is a biotechnology company that aims to improve the diagnosis and treatment of various diseases. They specialize in the development of innovative biomedical solutions, including advanced diagnostic tools and therapeutic options. Their team of dedicated scientists and researchers work towards the advancement of healthcare by translating scientific discoveries into practical applications. They collaborate with academic institutions, healthcare providers, and industry partners to transform the field of biomedicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

17 Patents

#1 in Pamplona

#119 in Spain

#34,831 in the World

Pamplona, Spain

Proyecto De Biomedicina Cima, S.l.

Forward Citations = 55

58 inventors:

Jesús Maria Prieto Valtueña (6 out of 7 patents)

Juan José Lasarte Sagastibelza (4 out of 7 patents)

Josune Orbe Lopategui (3 out of 3 patents)

4. Esther Larrea Leoz (3 out of 3 patents)

5. Inés Noelia Casares Lagar (2 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…